Phase I/II study of S 49076, a MET/AXL/FGFR inhibitor, in combination with gefitinib in EGFR-mutated NSCLC patients who progress on EGFR tyrosine kinase inhibitor
Autor: | Valérie Cattan, C-C. Lin, Makoto Nishio, Fortunato Ciardiello, Toyoaki Hida, Wan-Teck Lim, C. Gabarroca, F. Cantero, Haruyasu Murakami, Luis Paz-Ares, K. Park, E. Gandossi |
---|---|
Rok vydání: | 2017 |
Předmět: | |
Zdroj: | Annals of Oncology. 28:v493 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |